{"": [117, 1631, 0, 29042, 29067, 0], "Introduction": [1632, 5048, 0], "Description of participants": [5058, 6752, 0], "Neutralization assays": [6753, 9087, 0], "Kinetics of neutralizing antibodies": [9088, 11247, 0], "Association of neutralizing antibodies with age and gender": [11248, 12859, 0], "Impact of treatment on neutralizing titers": [12860, 14019, 0], "Results": [5049, 14019, 1], "Discussion": [14020, 20689, 0], "Participants": [20713, 22170, 0], "Samples and COVID-19 tests": [22171, 23737, 0], "Virus neutralization assay": [23738, 25019, 0], "Pseudovirus neutralization assay": [25020, 26763, 0], "Statistical analysis": [26764, 29014, 0], "Materials and methods": [20690, 29014, 1], "Supplementary information": [29015, 29067, 1]}